Into the unknown: Tarsus’ CEO on its launch strategies in a new disease category

Patients with the eyelid disease demodex blepharitis frequently follow a similar treatment journey — one Dr. Bobak Azamian, CEO of Tarsus Pharmaceuticals, witnessed up close when his mother started having problems with her eyes.